GlaxoSmithKline RSV vaccine (investigational or specified in study)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline RSV vaccine (investigational or specified in study), covering 2026-07-29 to 2026-07-29. Get the full timeline:
Most recent: Clinical Trial Update: An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study [Phase 3]